Ixchiq now has a warning about its use among elderly people with multiple underlying health conditions after postmarketing ...

In a video interview with MHE editors, Sharon Faust, Pharm.D., MBA, senior vice president and chief pharmacy officer at Navitus Health Solutions, shared that while she originally saw herself as a ...

Modeyso is the first drug to treat patients with diffuse midline glioma with an H3 K27M mutation, an ultra-rare and aggressive brain tumor.

An expert discusses the growing importance of real-world evidence in informing payer decisions and value-based care strategies for bispecific therapies in relapsed/refractory multiple myeloma (R/R MM) ...

An expert discusses how treatment guidelines and institutional pathways are evolving to integrate CAR T-cell therapies and bispecific antibodies for relapsed/refractory multiple myeloma (R/R MM), ...

In this final video part of a three-part video interview series, Brian Anderson, MBA, principal and consulting actuary at Milliman, told MHE he sees a more complex picture when it comes to ...

Colorectal cancer screening rates in young adults rise with effective outreach strategies, highlighting the importance of FIT kits for early detection.

In this second part of a three-part video interview series, Brian Anderson, MBA, a principal and consulting actuary at Milliman, shared his belief that PBM transparency is essential—but he sees risks ...

In a video interview with MHE editors, Nathan Downhour, Pharm.D., vice president of strategic pharmacy solutions at Prime Therapeutics, said a shift is already underway in the pharmacy benefit market ...